How long should you stay on a GLP-1 medication?

Short answer: There is no fixed course length. GLP-1 therapy for weight management is generally approached the way clinicians approach treatment for other chronic conditions: continued while it is working, tolerated and clinically appropriate, and reassessed regularly. In practice that means a gradual escalation phase of roughly four to five months, an active phase measured in months, and — for many people — a maintenance phase at a stable dose. Your provider reassesses at each cycle. Some patients transition off with a structured maintenance plan; others continue longer-term. It is a clinical decision, not a package you purchase in advance.

Escalation phase: roughly 16–20 weeks in most protocols.
Active phase: months, with cycle-by-cycle provider reassessment.
Maintenance: a stable dose for many patients; a structured off-ramp for others.
No long-term contract — billing runs every 28 days and you can cancel between cycles.

Begin Eligibility Review See Plans & Pricing

What gets reassessed

Response to date, tolerability, blood pressure and relevant labs, nutrition and training adherence, and your goals. If the medication is not producing benefit at a tolerated dose, continuing indefinitely is not automatically the right answer — that conversation belongs with your provider.

Frequently asked questions

Is there a minimum commitment?

No. Billing runs every 28 days and you can pause or cancel between cycles.

What is a maintenance dose?

A stable dose that preserves benefit with tolerable side effects, rather than continuing to escalate. Your provider determines whether maintenance is appropriate.

Will my provider tell me when to stop?

Your provider reviews progress each cycle and will discuss changes, including tapering, when clinically appropriate.

Program details

Patient education, not medical advice. Compounded medications are not FDA-approved. RenewMD does not serve Louisiana.